Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL

Simon Husby; Cecilie Baech-Laursen; Christian W. Eskelund; Francesco Favero; Jakob Schmidt Jespersen; Martin Hutchings; Lone Bredo Pedersen; Carsten U. Niemann; Joachim Weischenfeldt; Riikka Räty; Thomas Stauffer Larsen; Arne Kolstad; Mats Jerkeman; Kirsten Gronbaek

doi:10.1038/s41375-022-01725-8

Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL

Simon Husby, Cecilie Baech-Laursen, Christian W. Eskelund, Francesco Favero, Jakob Schmidt Jespersen, Martin Hutchings, Lone Bredo Pedersen, Carsten U. Niemann, Joachim Weischenfeldt, Riikka Räty, Thomas Stauffer Larsen, Arne Kolstad, Mats Jerkeman, Kirsten Gronbaek

HUS Cancercentrum

Forskningsoutput: Tidskriftsbidrag › Brev › Vetenskaplig

Originalspråk	engelska
Tidskrift	Leukemia
Volym	36
Sidor (från-till)	2912–2916
Antal sidor	5
ISSN	0887-6924
DOI	https://doi.org/10.1038/s41375-022-01725-8
Status	Publicerad - 2022
MoE-publikationstyp	B1 Artikel i en vetenskaplig tidskrift

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1038/s41375-022-01725-8

Citera det här

Husby, S., Baech-Laursen, C., Eskelund, C. W., Favero, F., Jespersen, J. S., Hutchings, M., Pedersen, L. B., Niemann, C. U., Weischenfeldt, J., Räty, R., Larsen, T. S., Kolstad, A., Jerkeman, M., & Gronbaek, K. (2022). Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL. Leukemia, 36, 2912–2916. https://doi.org/10.1038/s41375-022-01725-8

@article{abf6bac87d704745b3babb07e7373455,

title = "Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL",

keywords = "SINGLE-ARM, OPEN-LABEL, RITUXIMAB, LYMPHOMA, 3122 Cancers",

author = "Simon Husby and Cecilie Baech-Laursen and Eskelund, {Christian W.} and Francesco Favero and Jespersen, {Jakob Schmidt} and Martin Hutchings and Pedersen, {Lone Bredo} and Niemann, {Carsten U.} and Joachim Weischenfeldt and Riikka R{\"a}ty and Larsen, {Thomas Stauffer} and Arne Kolstad and Mats Jerkeman and Kirsten Gronbaek",

year = "2022",

doi = "10.1038/s41375-022-01725-8",

language = "English",

volume = "36",

pages = "2912–2916",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

}

Husby, S, Baech-Laursen, C, Eskelund, CW, Favero, F, Jespersen, JS, Hutchings, M, Pedersen, LB, Niemann, CU, Weischenfeldt, J, Räty, R, Larsen, TS, Kolstad, A, Jerkeman, M & Gronbaek, K 2022, 'Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL', Leukemia, vol. 36, s. 2912–2916. https://doi.org/10.1038/s41375-022-01725-8

TY - JOUR

T1 - Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL

AU - Husby, Simon

AU - Baech-Laursen, Cecilie

AU - Eskelund, Christian W.

AU - Favero, Francesco

AU - Jespersen, Jakob Schmidt

AU - Hutchings, Martin

AU - Pedersen, Lone Bredo

AU - Niemann, Carsten U.

AU - Weischenfeldt, Joachim

AU - Räty, Riikka

AU - Larsen, Thomas Stauffer

AU - Kolstad, Arne

AU - Jerkeman, Mats

AU - Gronbaek, Kirsten

PY - 2022

Y1 - 2022

KW - SINGLE-ARM

KW - OPEN-LABEL

KW - RITUXIMAB

KW - LYMPHOMA

KW - 3122 Cancers

U2 - 10.1038/s41375-022-01725-8

DO - 10.1038/s41375-022-01725-8

M3 - Letter

VL - 36

SP - 2912

EP - 2916

JO - Leukemia

JF - Leukemia

SN - 0887-6924

ER -